A study conducted at Turku PET Center in Finland showed that changes in the functioning of opioid neurotransmitters in the ...

Discover how changes in opioid neurotransmitters in the brain may influence anorexia nervosa, affecting appetite, anxiety, ...

New research found that individuals with anorexia nervosa have elevated opioid neurotransmitter activity, which may contribute to appetite loss and emotional symptoms. A study from the Turku PET Centr ...

A study showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

Are dropping fentanyl-related death rates concealing other issues in the fight against this brutal form of addiction?

A study conducted at Turku PET Centre in Finland showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

An opioid overdose occurs when opioids have fully blocked the brain's opioid receptors, causing a person's breathing to slow down and ultimately stop. Naloxone works by knocking the opioids out of ...

Purpose. Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

The Sacklers will no longer have liability protection from future lawsuits. The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial ...